Kohlberg Kravis Roberts ( (KKR) ) has released its Q2 earnings. Here is a breakdown of the information Kohlberg Kravis Roberts presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
KKR & Co. Inc. is a global investment firm known for its alternative asset management, capital markets, and insurance solutions, focusing on generating attractive investment returns through a disciplined approach and strategic partnerships.
In its second quarter of 2025, KKR reported significant financial growth, with a notable increase in Fee Related Earnings, Total Operating Earnings, and Adjusted Net Income, reflecting a strong performance across its diverse investment strategies.
Key highlights from the quarter include a 14% year-over-year growth in Assets Under Management to $686 billion, a strategic acquisition of HealthCare Royalty Partners, and robust capital raising activities totaling $28 billion for the quarter. The firm’s Fee Related Earnings rose by 17% year-over-year, while Total Operating Earnings and Adjusted Net Income saw increases of 14% and 9%, respectively.
KKR’s strategic acquisition of a majority stake in HealthCare Royalty Partners aims to enhance its capabilities in biopharma royalty and credit investing, further expanding its footprint in the life sciences ecosystem. The firm also declared a regular dividend of $0.185 per share of common stock for the quarter.
Looking ahead, KKR remains optimistic about its growth prospects, supported by its strong financial performance and strategic initiatives, positioning itself well for continued success in the second half of the year.